Csenge Advisory Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $699K | Sell |
|
|||||
|
2025
Q1 | $584K | Sell |
|
|||||
|
2024
Q4 | $900K | Sell |
|
|||||
|
2024
Q3 | $3.37M | Buy |
|
|||||
|
2024
Q2 | $3.93M | Buy |
|
|||||
|
2024
Q1 | $2.99M | Buy |
|
|||||
|
2023
Q4 | $2.02M | Buy |
|
|||||
|
2023
Q3 | $887K | Buy |
|
|||||
|
2023
Q2 | $534K | Buy |
|
|||||
|
2023
Q1 | $329K | Sell |
|
|||||
|
2022
Q4 | $302K | Sell |
|
|||||
|
2022
Q3 | $253K | Buy |
|
|||||
|
2022
Q2 | $273K | Sell |
|
|||||
|
2022
Q1 | $274K | Buy |
|
|||||
|
2021
Q4 | $203K | Sell |
|
|||||
|
2021
Q3 | $246K | Buy |
|
|||||
|
2021
Q2 | $203K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1K | Buy |
|